• Dabigatran, apixaban, and rivaroxaban were as effective as warfarin in reducing the risk of stroke in patients with severe obesity and AF
  • Furthermore, these drugs were associated with more favorable safety including lower rates of bleeding and hemorrhagic stroke compared with warfarin